CPRX
NASDAQ · Biotechnology
Catalyst Pharmaceuticals Inc
$31.49
+0.01 (+0.03%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+57.06%
YTD
+36.03%
Open$31.48
Previous Close$31.48
Day High$31.51
Day Low$31.48
52W High$32.56
52W Low$19.05
Volume—
Avg Volume3.49M
Market Cap3.85B
P/E Ratio17.42
EPS$1.74
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$23.76
Above
SMA 200
$22.30
Above
RSI (14)
48.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Sell
9 analysts
Price Target
+59.2% upside
Current
$31.49
$31.49
Target
$50.13
$50.13
$36.48
$50.13 avg
$69.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 566.58M | 404.41M | 680.16M |
| Net Income | 206.18M | 132.45M | -27,885,830 |
| Profit Margin | 36.4% | 34.6% | -4.1% |
| EBITDA | 284.05M | 192.61M | -33,860,903 |
| Free Cash Flow | — | — | -33,852,425 |
| Rev Growth | +40.1% | +40.1% | +20.9% |
| Debt/Equity | — | — | 0.20 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $263.96 | -0.02% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $385.65 | +1.55% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.11 | -0.52% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $508.34 | -1.55% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $784.85 | -0.58% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $239.56 | -2.42% | 40.0 | 32.33B |